-
Clinical impact of additional findings detected by genome-wide non-invasive prenatal testing: Clinical impact of additional findings detected by genome-wide non-invasive prenatal testing: Follow-up results of the TRIDENT-2 study (The American Journal of Human Genetics (2022) 109(6) (1140–1152), (S0002929722002051), (10.1016/j.ajhg.2022.04.018))
Dutch NIPT Consortium, 7 Jul 2022, In: American journal of human genetics. 109, 7, p. 1344 1 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Clinical impact of additional findings detected by genome-wide non-invasive prenatal testing: Follow-up results of the TRIDENT-2 study
The Dutch NIPT Consortium & Dutch NIPT Consortium, 2 Jun 2022, In: American journal of human genetics. 109, 6, p. 1140-1152 13 p.Research output: Contribution to journal › Article › Academic › peer-review
-
TRIDENT-2: National Implementation of Genome-wide Non-invasive Prenatal Testing as a First-Tier Screening Test in the Netherlands
The Dutch NIPT Consortium, Kooper, A. J. A. & Dutch NIPT Consortium, 5 Dec 2019, In: American journal of human genetics. 105, 6, p. 1091-1101 11 p.Research output: Contribution to journal › Article › Academic › peer-review
- All publications
